Atossa Genetics (NASDQ: ATOS) is a clinical-stage drug company developing novel, proprietary therapeutics and delivery methods for breast cancer and other breast conditions.
Visit our YouTube channel to learn more about Atossa Genetics.
Atossa Genetics Announces Second Quarter 2017 Financial Results And Provides Company Update
Atossa Genetics Completes Enrollment in Endoxifen Phase 1 Study and Provides Update on Fulvestrant Microcatheter Phase 2 Study
Atossa Genetics Announces Warrant Exercises
More Press Releases
Learn more about Atossa Genetics
Learn more about our programs
Contact Atossa Genetics today!